Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,327 | $5,279 | $6,435 | $9,585 |
| - Cash | $3,622 | $3,891 | $3,829 | $5,682 |
| + Debt | $974 | $1,257 | $1,291 | $1,081 |
| Enterprise Value | $680 | $2,644 | $3,897 | $4,984 |
| Revenue | $1,901 | $1,861 | $2,181 | $3,038 |
| % Growth | 2.2% | -14.7% | -28.2% | – |
| Gross Profit | $1,242 | $1,296 | $1,488 | $2,430 |
| % Margin | 65.3% | 69.6% | 68.2% | 80% |
| EBITDA | $105 | $334 | -$1,542 | $932 |
| % Margin | 5.5% | 18% | -70.7% | 30.7% |
| Net Income | -$217 | -$54 | -$1,915 | $417 |
| % Margin | -11.4% | -2.9% | -87.8% | 13.7% |
| EPS Diluted | -0.023 | -0.006 | -0.21 | 0.044 |
| % Growth | -303.4% | 97.2% | -578.4% | – |
| Operating Cash Flow | $244 | $199 | $46 | $665 |
| Capital Expenditures | -$186 | -$295 | -$402 | -$601 |
| Free Cash Flow | $58 | -$96 | -$356 | $64 |